US 11534439
Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors
granted A61KA61K31/498A61K31/4985
Quick answer
US patent 11534439 (Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/498, A61K31/4985, A61K45/06, A61P